Elixinol Wellness sells stake in Pet Releaf for A$2.3 million
SYDNEY, AUSTRALIA: Elixinol Wellness Limited (ASX: EXL), a global leader in hemp and plant-based products, has announced the sale of its minority interest in Altmed Pets, LLC (Pet Releaf), a US-based pet wellness company, for approximately A$2.3 million. The deal, which is subject to financing, will allow Elixinol Wellness to focus on its core business…
